Clinical Trials at Alegent Creighton Health
|Study Group||Alegent Creighton Health Heart & Vascular (Ref number:156)|
|Description||TIMI 54- PEGASUS|
|Study Number||TIMI 54- PEGASUS|
|Contact Name||Barb Lapke|
|Additional Information||This study is being carried out to see if a new drug called ticagrelor given twice daily in addition to the ASA therapy decreases the frequency of cardiovascular events (e.g., death from heart disease, heart attack, or stroke).